The Cooper Companies, Inc. $COO Shares Acquired by Rhenman & Partners Asset Management AB

Posted by Brian Himes on Jun 13th, 2026

Rhenman & Partners Asset Management AB grew its position in The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 38.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 327,500 shares of the medical device company’s stock after acquiring an additional 90,500 shares during the quarter. Cooper Companies comprises approximately 2.5% of Rhenman & Partners Asset Management AB’s portfolio, making the stock its 6th biggest position. Rhenman & Partners Asset Management AB’s holdings in Cooper Companies were worth $26,842,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the company. Quadrant Capital Group LLC boosted its holdings in shares of Cooper Companies by 127.3% in the fourth quarter. Quadrant Capital Group LLC now owns 7,750 shares of the medical device company’s stock valued at $635,000 after acquiring an additional 4,340 shares during the period. Beck Mack & Oliver LLC acquired a new stake in shares of Cooper Companies in the fourth quarter valued at approximately $3,360,000. DRW Securities LLC acquired a new stake in shares of Cooper Companies in the fourth quarter valued at approximately $224,000. Brooklyn Investment Group boosted its holdings in shares of Cooper Companies by 11.9% in the fourth quarter. Brooklyn Investment Group now owns 4,703 shares of the medical device company’s stock valued at $387,000 after acquiring an additional 499 shares during the period. Finally, Generation Investment Management LLP acquired a new stake in shares of Cooper Companies in the fourth quarter valued at approximately $233,539,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

COO has been the subject of several research analyst reports. Wells Fargo & Company reissued a “sell” rating and issued a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. Robert W. Baird decreased their price objective on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a report on Friday, June 5th. Wall Street Zen downgraded Cooper Companies from a “buy” rating to a “hold” rating in a report on Saturday. Mizuho set a $85.00 price objective on Cooper Companies and gave the company an “outperform” rating in a report on Thursday, June 4th. Finally, Needham & Company LLC decreased their price objective on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, five have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $82.64.

Check Out Our Latest Analysis on Cooper Companies

Cooper Companies Stock Up 0.5%

Shares of Cooper Companies stock opened at $67.88 on Friday. The company has a market cap of $13.24 billion, a P/E ratio of 57.53, a PEG ratio of 1.77 and a beta of 0.87. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The firm has a fifty day moving average of $64.79 and a two-hundred day moving average of $74.35.

Cooper Companies (NASDAQ:COO – Get Free Report) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. Cooper Companies’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies Company Profile

(Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.